Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds
Skin Brightening: Contains Glutathione, a potent antioxidant known for its skin-lightening benefits, which helps to reduce the appearance of dark spots, hyperpigmentation, and uneven skin tone for a more luminous complexion
These lines form primarily from early collagen decline, dehydration, and minor elastin degradation, all factors that GHK-Cu directly addresses
Fights the signs of aging - With collagen-boosting and anti-inflammatory properties, glutathione helps reverse the signs of aging such as fine lines, skin-sagging, and skin irritations